Clinical Trials Logo

Clinical Trial Summary

To assess the residual risk of OrthoVisc-T (OVT) for the treatment of chronic lateral epicondylosis (Tennis Elbow). This trial will provide clinical data on a subject population not previously researched which have failed prior treatments for lateral epicondylosis.


Clinical Trial Description

Orthovisc-T is a sterile viscoelastic preparation supplied in a disposable glass syringe containing 2.0 mL of sodium hyaluronate (15 mg/mL) dissolved in physiological saline. The Orthovisc-T device is intended to relieve pain and restore function in tendons affected by chronic lateral epicondylosis. The hyaluronic acid solution provides extracellular supplementation of the elbow with lateral epicondylosis, lubricating and hydrating the affected site, thereby providing the ideal environment for healing of the damaged tissue. The objective of the study is to evaluate the residual risk of two peri-osteotendinous injections of Orthovisc-T spaced one week apart for the relief of elbow pain and to restore function in patients with lateral epicondylosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04026191
Study type Interventional
Source Anika Therapeutics, Inc.
Contact
Status Completed
Phase N/A
Start date July 19, 2019
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05238090 - Efficacy of a Stretching Protocol for Lateral Epicondylitis N/A
Recruiting NCT06442618 - Effectiveness of Extracorporeal Shockwave Therapy and Nutraceutical Supplementation in the Treatment of Epicondylitis: a Clinical Trial N/A
Completed NCT04875338 - Injection in the Treatment of Lateral Epicondylitis. Randomized Controlled Trial Phase 3
Recruiting NCT04194710 - Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis N/A
Completed NCT06160011 - Epicondylar Muscle Activation in Tennis Players N/A